According to Precedence Research, the global drug of abuse testing market size was estimated at US$ 4.90 billion in 2022 and is expected to hit US$ 9.15 billion by 2032, poised to grow at a noteworthy compound annual growth rate (CAGR) of 6.5% from 2023 to 2032.
Key Takeaway
Growth Factors
The drug of abuse testing market is primarily driven by the factors such as strict laws that mandates the drug abuse testing, growing government initiatives regarding drug abuse, increased consumption of alcohol and other drugs, and increasing mortality due to drugs. Moreover, an increase in the number of clinics and research labs have been witnessed in the past few years that provides drug of abuse testing services. The development of cost effective testing kits and technological advancements in this field has promoted the growth of the market across the globe.
The production and consumption of drugs is growing across the world. According to the United Nations Office on Drugs and Crime, around 246 million people used illicit drug and the population aged between 15 and 64 years, in 2013. A rise of 3 million people was recorded as compared to the previous year. Further, in 2013, around 27 million people were suffering from drug use disorder. Around 24% to 36% of the heroin consuming population passes through correctional system annually in US. Moreover, studies have found that there is a growing prevalence of HIV amongst the people who continues to inject drugs. According to UNDOC, around 40% of the global people who inject drugs are infected with HIV. Hence, the rising prevalence of HIV is a major factor that encourages the restriction on drug use, thereby propelling the growth of the global drug of abuse testing market.
Report Scope of the Drug of Abuse Testing Market
| Report Highlights | Details |
| Market Size in 2023 | US$ 5.19 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 6.5% |
| Market Size by 2032 | US$ 9.15 Billion |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Drug Type, Sample Type, End User, Region |
| Companies Mentioned | Danaher Corporation, Abbott Laboratories, Quest Diagnostics, Inc., LabCorp, Cordant Health Solutions, Legacy Medical Services, Mayo Clinic Laboratories, DrugScan, LGC Group, Precision Diagnostics |
Drug Type Insights
By drug type, the marijuana/cannabis segment led the global drug of abuse testing market with remarkable revenue share in 2022. This is solely attributable to the growth in the production and consumption of marijuana across the globe. As per the data revealed by the Substance abuse & Mental Health Service Administration, in 2018, around 43.5 million people used marijuana.
On the other hand, the opioids segment is gaining traction due to its growing consumption among the population. According to the National Center for Drug Abuse Statistics, around 2 million US people had opioids use disorder in 2018.
Sample Type Insights
By sample type, the urine segment led the global drug of abuse testing market with remarkable revenue share in 2022. Urine analysis is the most common type of sample testing to detect drug of abuse. Moreover it is widely used by the work places and criminal justice systems. Further, the growing number of medical centers and clinical labs is fostering the segment growth. The urine analysis is cheap that further boos the growth of this segment across the globe.
End User Insights
By end user, the workplaces segment led the global drug of abuse testing market with remarkable revenue share in 2022.
The workplaces extensively uses the drug of abuse testing to ensure that the employees are free from any drug addiction and can dedicate their time to work efficiently.
Region Insights
Based on the region, the North America dominated the global drug of abuse testing market in 2022, in terms of revenue and is estimated to sustain its dominance during the forecast period. This is attributed to the extensive use and consumption of drugs in the major market like the US. Further, the presence of numerous key market players in the region and their strategical developments fueled the growth of the drug of abuse market in this region.Around 24% to 36% of the heroin consuming population passes through correctional system annually in US. The increasing rate of substance use disorder in North America is fostering the market growth. Further, the growing government initiative to trace the use of drugs among the population is facilitating the adoption of drug of abuse testing. For instance, the government of US implemented Patients and Communities Act to counter the problem of drug abuse.
On the other hand, Asia Pacific is estimated to be the most opportunistic market during the forecast period. The emerging nations such as India and China is expected to foster the demand for the drug of abuse testing demand in the forthcoming years. The growing consumption of illicit drugs and the growing government initiative to counter the excessive use of drugs among the youth is significantly driving the drug of abuse testing market in this region.
Key Companies & Market Share Insights
Some of the prominent players:
Market Segmentation
By Drug Type
By Sample Type
By Product
By Application
By End User
By Geography
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client
